Pneumococcal vaccines for children and adults with bronchiectasis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Chang, Christina C ^a   Singleton, R J ^b   Morris, P S ^b   Chang, A B ^b  

^a GEELONG HOSPITAL   (Australia)

^b NONE

Author keywords

Adult; Bronchiectasis *complications ; Child; Humans; Pneumococcal infections *prevention control ; Pneumococcal vaccines *therapeutic use

Indexed keywords

PNEUMOCOCCUS VACCINE;

BRONCHIECTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 44949088542     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006316.pub2     Document Type: Review

References (37)

1. Ryzhov 2005 Ryzhov AA, Katosova LK, Kostinov MP, Volkov IK, Magarshak OO. Evaluation of the influence of the bacterial vaccines Pneumo-23 and Act-HIB on the course of the chronic inflammatory process of the respiratory organs in children. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii 2005;30(3):84-7.
2. van Kessel 2005 van Kessel DA, van Velzen-Blad H, van den Bosch JM, Rijkers GT. Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. European Respiratory Journal 2005;25(3):482-9.
3. Vendrell 2005 Vendrell M, De Gracia J, Rodrigo MJ, Cruz MJ, Alvarez A, Garcia M, et al.Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 2005;127(1):197-204.
4. ACIP ACIP. Advisory Committee on Immunization Practices. http://www.cdc.gov/nip/menus/vaccines.htm accessed Dec 2006.
5. Callahan 2002 Callahan CW, Redding GJ. Bronchiectasis in children: orphan disease or persistent problem?. Pediatric pulmonology 2002;33(6):492-496.
6. Cates 2003 Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma (Cochrane Review). Cochrane Database of Systematic Reviews 2003, Issue 4.Art. No.: CD000364. DOI:10.1002/14651858.CD000364.pub2. .
7. Chang 1998 Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatric Radiology 1998;28(1):23-29.
8. Chang 2002 Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in Indigenous children in remote Australian communities. Medical Journal of Australia 2002;177(4):200-4.
9. Cole 1986 Cole PJ. Inflammation: a two edged sword. The model of bronchiectasis. European Journal Respiratory Disease 1986; 147(Suppl):6-15.
10. Conaty 2004 Conaty S, Watson L, Dinnes J, Waugh N. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. Vaccine 2004;22(23-24):3214-24.
11. de Roux 2005 de Roux A, Lode H. Pneumococcal vaccination. European Respiratory Journal 2005;26(6):982-3.
12. Devitt 1977 Devitt L, Riley I, Hansman D. Human infection caused by penicillin-insensitive pneumococci. Medical Journal of Australia 1977;1(16):586-8.
13. Edwards 2003 Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. Journal of Paediatrics & Child Health 2003;39(2):111-7.
14. Forrester 1987 Forrester HL, Jahnigen DW, LaForce FM. Inefficacy of pneumococcal vaccine in a high-risk population. American Journal of Medicine 1987;83(3):425-30.
15. Granger 2006 Granger R, Walters J, Poole PJ, Lasserson TJ, Mangtani P, Cates CJ, et al.Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD001390. DOI:10.1002/14651858.CD001390.pub2..
16. Gursel 2006 Gursel G. Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease?. Heart Lung 2006;35(1):58-65.
17. Honkanen 1999 Honkanen PO, Keistinen T, Miettinen L, Herva E, Sankilampi U, Laara E, et al.Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999;17(20-21):2493-500.
18. Jackson 2006 Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D, et al.Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine 2006;24(2):151-6.
19. Jefferson 2006 Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006;333(7574):912-5.
20. Karadag 2005 Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cysticfibrosis bronchiectasis in children: a persisting problemin developing countries. Respiration 2005;72(3):233-8.
21. Karakoc 2001 Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatric Pulmonology 2001;32(2):175-8.
22. Kay 2005 Kay E, Ng K, Salmon A, Del MC. Influenza vaccine for preventing acute otitis media in infants and children (Cochrane Protocol). Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD005438.. DOI:10.1002/14651858.CD005438..
23. Keistinen 1997 Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. European Respiratory Journal 1997;10(12):2784-7.
24. Lee 2003 Lee CJ, Lee LH, Frasch CE. Protective immunity of pneumococcal glycoconjugates. Critical Reviews in Microbiology 2003;29(4):333-49.
25. Lewis 2002 Lewis MM, Mortelliti MP, Yeager H, Jr, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis, vasculitis, and diffuse lung diseases 2002;19(2):154-9.
26. Lexau 2005 Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, et al.Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294(16):2043-51.
27. Lucero 2004 Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, et al.Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age (Cochrane Review). Cochrane Database of Systematic Reviews 2004, Issue 4.Art. No.: CD004977.. DOI:10.1002/14651858.CD004977..
28. Martinez-Garcia 2005 Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005;128(2):739-45.
29. McEllistrem 2005 McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al.Acute otitis media due to penicillin- nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clinical Infectious Diseases 2005;40(12):1738-44.
30. NIPS National Immunisation Program. http://www.immunise.health. gov.au/internet/immunise/publishing.nsf/Content/nips accessed Dec 2006.
31. O'Brien 2000 O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55(8):635-42.
32. Patel 2004 Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al.Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 2004;170(4):400-7.
33. Sheikh 2002 Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma (CochraneReview). Cochrane Database of Systematic Reviews 2002, Issue 1.Art. No.: CD002165.. DOI:10.1002/14651858.CD002165..
34. Singleton 2000 Singleton RJ, Morris A, Redding G, Poll J, Holck P, Martinez P, et al.Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatric Pulmonology 2000;29(3):182-7.
35. Straetemans 2004 Straetemans M, Sanders EAM, Veenhoven RH, Schilder AGM, Damoiseaux RAMJ, Zielhuis GA. Pneumococcal vaccines for preventing otitis media (Cochrane Review). Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD001480. DOI: 10.1002/14651858.CD001480.pub2. .
36. Twiss 2006 Twiss J, Stewart AW, Byrnes CA. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax 2006;61(5):414-8.
37. Walker 2005 Walker FJ, Singleton RJ, Bulkow LR, Strikas RA, Butler JC. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Clinical Infectious Diseases 2005;40(12):1730-5.